Novel, Single-Dose Microsphere Formulation of Azithromycin Versus 7-Day Levofloxacin Therapy for Treatment of Mild to Moderate Community-Acquired Pneumonia in Adults

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.49.10.4035-4041.2005
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Single Versus Combination Antibiotic Therapy in Adults Hospitalised With Community Acquired Pneumonia: Table 1

Thorax
PulmonaryRespiratory Medicine
2012English

Authors’ Response: Single Versus Combination Antibiotic Therapy in Adults Hospitalised With Community Acquired Pneumonia

Thorax
PulmonaryRespiratory Medicine
2013English

Antimicrobial Therapy for Community-Acquired Pneumonia in Adults

Brazilian Journal of Infectious Diseases
Infectious DiseasesMicrobiology
2002English

Full-Course Oral Levofloxacin for Treatment of Hospitalized Patients With Community-Acquired Pneumonia

European Journal of Clinical Microbiology and Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2004English

Switch Therapy in Hospitalized Patients With Community-Acquired Pneumonia: Tigecycline vs. Levofloxacin

BMC Infectious Diseases
Infectious Diseases
2012English

Effectiveness of Discontinuing Antibiotic Treatment After Three Days Versus Eight Days in Mild to Moderate-Severe Community Acquired Pneumonia: Randomised, Double Blind Study

BMJ
2006English

Azithromycin Monotherapy for Patients Hospitalized With Community-Acquired Pneumonia

Archives of Internal Medicine
2003English

Respiratory Fluoroquinolones vs. Other Commonly Used Antimicrobials in Mild-To-Moderate Severity Community-Acquired Pneumonia

The International Arabic Journal of Antimicrobial Agents
2015English

Microbiologic Efficacy of Azithromycin and Susceptibilities to Azithromycin of Isolates of Chlamydia Pneumoniae From Adults and Children With Community-Acquired Pneumonia

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1998English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy